Literature DB >> 33552481

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease.

Eric M Przybyszewski1, Giovanni Targher2, Michael Roden3,4,5, Kathleen E Corey6.   

Abstract

Watch a video presentation of this article Answer questions and earn CME.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2021        PMID： 33552481      PMCID： PMC7849297          DOI： 10.1002/cld.1017

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  10 in total

1.  Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease.

Authors:  Kathleen E Corey; Uri Kartoun; Hui Zheng; Raymond T Chung; Stanley Y Shaw
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

2.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Authors:  Mattias Ekstedt; Hannes Hagström; Patrik Nasr; Mats Fredrikson; Per Stål; Stergios Kechagias; Rolf Hultcrantz
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

Review 3.  A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

Authors:  Mohammed Eslam; Philip N Newsome; Shiv K Sarin; Quentin M Anstee; Giovanni Targher; Manuel Romero-Gomez; Shira Zelber-Sagi; Vincent Wai-Sun Wong; Jean-François Dufour; Jörn M Schattenberg; Takumi Kawaguchi; Marco Arrese; Luca Valenti; Gamal Shiha; Claudio Tiribelli; Hannele Yki-Järvinen; Jian-Gao Fan; Henning Grønbæk; Yusuf Yilmaz; Helena Cortez-Pinto; Claudia P Oliveira; Pierre Bedossa; Leon A Adams; Ming-Hua Zheng; Yasser Fouad; Wah-Kheong Chan; Nahum Mendez-Sanchez; Sang Hoon Ahn; Laurent Castera; Elisabetta Bugianesi; Vlad Ratziu; Jacob George
Journal:  J Hepatol       Date:  2020-04-08       Impact factor: 25.083

4.  Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Andrew Paul DeFilippis; Michael J Blaha; Seth S Martin; Robert M Reed; Steven R Jones; Khurram Nasir; Roger S Blumenthal; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2013-01-29       Impact factor: 5.162

5.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Chisato Nagata; Jun Takeda; Hiroshi Sarui; Yutaka Kawahito; Naohisa Yoshida; Atsushi Suetsugu; Takahiro Kato; Junichi Okuda; Kazunori Ida; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

6.  Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia.

Authors:  Pierre Blais; Michael Lin; Jennifer R Kramer; Hashem B El-Serag; Fasiha Kanwal
Journal:  Dig Dis Sci       Date:  2015-12-26       Impact factor: 3.199

Review 7.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

8.  Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease.

Authors:  Jacqueline B Henson; Tracey G Simon; Alyson Kaplan; Stephanie Osganian; Ricard Masia; Kathleen E Corey
Journal:  Aliment Pharmacol Ther       Date:  2020-02-11       Impact factor: 8.171

9.  Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.

Authors:  Giovanni Targher; Christopher D Byrne; Amedeo Lonardo; Giacomo Zoppini; Corrado Barbui
Journal:  J Hepatol       Date:  2016-05-17       Impact factor: 25.083

Review 10.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690
  10 in total
  5 in total

1.  Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost.

Authors:  Wai Hoong Chang; Stefanie H Mueller; Sheng-Chia Chung; Graham R Foster; Alvina G Lai
Journal:  J Transl Med       Date:  2022-01-03       Impact factor: 5.531

Review 2.  Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease.

Authors:  Gashaw Hassen; Abhishek Singh; Gizeshwork Belete; Nidhi Jain; Ivonne De la Hoz; Genesis P Camacho-Leon; Nitsuh K Dargie; Keila G Carrera; Tadesse Alemu; Sharan Jhaveri; Nebiyou Solomon
Journal:  Cureus       Date:  2022-05-30

3.  The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.

Authors:  Cheng Han Ng; Kai En Chan; Yip Han Chin; Rebecca Wenling Zeng; Pei Chen Tsai; Wen Hui Lim; Darren Jun Hao Tan; Chin Meng Khoo; Lay Hoon Goh; Zheng Jye Ling; Anand Kulkarni; Lung-Yi Loey Mak; Daniel Q Huang; Mark Chan; Nicholas Ws Chew; Mohammad Shadab Siddiqui; Arun J Sanyal; Mark Muthiah
Journal:  Clin Mol Hepatol       Date:  2022-05-19

Review 4.  Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Hans-Michael Steffen; Philipp Kasper; Anna Martin; Sonja Lang; Tobias Goeser; Münevver Demir
Journal:  Curr Atheroscler Rep       Date:  2022-05-04       Impact factor: 5.967

Review 5.  New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis.

Authors:  Georgiana-Diana Cazac; Cristina-Mihaela Lăcătușu; Cătălina Mihai; Elena-Daniela Grigorescu; Alina Onofriescu; Bogdan-Mircea Mihai
Journal:  Life (Basel)       Date:  2022-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.